Renovaro Inc. financial data

Symbol
RENB on Nasdaq
Industry
Pharmaceutical Preparations
Location
Century City Medical Plaza, 2080 Century City East, Suite 906 Los Angeles, CA
State of incorporation
DE
Fiscal year end
June 30
Former names
RENOVARO BIOSCIENCES INC. (to 2/7/2024), Enochian Biosciences Inc (to 8/1/2023), DanDrit Biotech USA, Inc. (to 2/23/2018), Putnam Hills Corp. (to 2/11/2014)
Latest financial report
10-Q - Q4 2024 - Feb 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 6.69 % -71.1%
Debt-to-equity 28.6 % +17.1%
Return On Equity -113 % -39.1%
Return On Assets -87.9 % -34.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 159M shares +10.5%
Common Stock, Shares, Outstanding 162M shares +141%
Entity Public Float 57.2M USD +25.9%
Common Stock, Value, Issued 16.2K USD +141%
Weighted Average Number of Shares Outstanding, Basic 162M shares +146%
Weighted Average Number of Shares Outstanding, Diluted 162M shares +146%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.07M USD -14.4%
General and Administrative Expense 22.3M USD +19.6%
Operating Income (Loss) -126M USD -215%
Nonoperating Income (Expense) 184K USD -945%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.18M USD -19.2%
Net Income (Loss) Attributable to Parent -126M USD -206%
Earnings Per Share, Basic -1.02 USD/shares -45.7%
Earnings Per Share, Diluted -1.02 USD/shares -45.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 312K USD +27.8%
Cash, Cash Equivalents, and Short-term Investments 91.4K USD -97.6%
Assets, Current 1.71M USD -28.9%
Property, Plant and Equipment, Net 422K USD -15.1%
Operating Lease, Right-of-Use Asset 1.18M USD +45.3%
Intangible Assets, Net (Excluding Goodwill) 0 USD
Goodwill 108M USD +828%
Other Assets, Noncurrent 109M USD +98.1%
Assets 111M USD +91.9%
Accrued Liabilities, Current 5.51M USD +603%
Liabilities, Current 28.6M USD +108%
Operating Lease, Liability, Noncurrent 674K USD +1.5%
Other Liabilities, Noncurrent 231K USD +25.3%
Liabilities 29.3M USD +103%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.85M USD -14029%
Retained Earnings (Accumulated Deficit) -384M USD -49%
Stockholders' Equity Attributable to Parent 82.1M USD +88.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 82.1M USD +88.2%
Liabilities and Equity 111M USD +91.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.02M USD +27.4%
Net Cash Provided by (Used in) Financing Activities 2.03M USD -20.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 350M shares +250%
Common Stock, Shares, Issued 162M shares +141%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.35M USD -12.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 312K USD +27.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 171M USD +18.2%
Depreciation 114K USD +5.82%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -130M USD -215%
Lessee, Operating Lease, Liability, to be Paid 1.34M USD +37.9%
Property, Plant and Equipment, Gross 1.06M USD +8.9%
Operating Lease, Liability, Current 562K USD +158%
Lessee, Operating Lease, Liability, to be Paid, Year Two 458K USD +80.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 554K USD +125%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +24.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 91K USD -13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 335K USD +28.3%
Deferred Tax Assets, Operating Loss Carryforwards 149M USD +5.9%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 309K USD
Operating Lease, Payments 108K USD +9.59%
Additional Paid in Capital 470M USD +55.9%
Preferred Stock, Shares Outstanding 0 shares -100%
Operating Leases, Future Minimum Payments, Due in Two Years 246K USD -17.5%
Amortization of Intangible Assets 8.3K USD +34.3%
Depreciation, Depletion and Amortization 126K USD +7.94%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 60K USD -31.6%
Share-based Payment Arrangement, Expense 465K USD -43.2%
Operating Leases, Future Minimum Payments, Due in Three Years 253K USD +3%
Operating Leases, Future Minimum Payments Due 1.04M USD -21.2%
Interest Expense 304K USD +148%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%